Also categorized in BoardNews:
Six Years Later, The Problem at HP is Still the Board
x hide permanently

Valeant Pharma plans improved offer for Allergan

Breaking News Headlines

Botox maker Allergan said Valeant's uncertain long-term growth prospects and business model create a risk for its shareholders

Mentions: Management CEO activist investor